196 related articles for article (PubMed ID: 31618793)
1. Trends in gamma-hydroxybutyrate-related harms based on ambulance attendances from 2012 to 2018 in Victoria, Australia.
Arunogiri S; Moayeri F; Crossin R; Killian JJ; Smith K; Scott D; Lubman DI
Addiction; 2020 Mar; 115(3):473-479. PubMed ID: 31618793
[TBL] [Abstract][Full Text] [Related]
2. Patterns and incidence of gamma-hydroxybutyrate (GHB)-related ambulance attendances in Melbourne, Victoria.
Dietze PM; Cvetkovski S; Barratt MJ; Clemens S
Med J Aust; 2008 Jun; 188(12):709-11. PubMed ID: 18558893
[TBL] [Abstract][Full Text] [Related]
3. Adverse outcomes of GHB use: Analysis of ambulance attendances in metropolitan and regional Victoria.
Ogeil RP; Faulkner A; Beard N; Killian JJ; Arunogiri S; Phan V; Wilson J; Smith K; Lubman DI; Scott D
Int J Drug Policy; 2023 Jan; 111():103932. PubMed ID: 36527909
[TBL] [Abstract][Full Text] [Related]
4. Hospital in the field: prehospital management of GHB intoxication by medical assistance teams.
Dutch MJ; Austin KB
Prehosp Disaster Med; 2012 Oct; 27(5):463-7. PubMed ID: 22809488
[TBL] [Abstract][Full Text] [Related]
5. Trends in cannabis-related ambulance presentations from 2000 to 2013 in Melbourne, Australia.
Kaar SJ; Gao CX; Lloyd B; Smith K; Lubman DI
Drug Alcohol Depend; 2015 Oct; 155():24-30. PubMed ID: 26361711
[TBL] [Abstract][Full Text] [Related]
6. Recent trends in heroin and pharmaceutical opioid-related harms in Victoria, Australia up to 2018.
Lam T; Kuhn L; Hayman J; Middleton M; Wilson J; Scott D; Lubman DI; Smith K; Nielsen S
Addiction; 2020 Feb; 115(2):261-269. PubMed ID: 31465131
[TBL] [Abstract][Full Text] [Related]
7. Comparing rates and characteristics of ambulance attendances related to extramedical use of pharmaceutical opioids in Victoria, Australia from 2013 to 2018.
Nielsen S; Crossin R; Middleton M; Lam T; Wilson J; Scott D; Martin C; Smith K; Lubman D
Addiction; 2020 Jun; 115(6):1075-1087. PubMed ID: 31742765
[TBL] [Abstract][Full Text] [Related]
8. Trends over time in characteristics of pharmaceutical drug-related ambulance attendances in Melbourne.
Lloyd BK; McElwee PR
Drug Alcohol Rev; 2011 May; 30(3):271-80. PubMed ID: 21545557
[TBL] [Abstract][Full Text] [Related]
9. Acute harms associated with inhalant misuse: Co-morbidities and trends relative to age and gender among ambulance attendees.
Crossin R; Scott D; Witt KG; Duncan JR; Smith K; Lubman DI
Drug Alcohol Depend; 2018 Sep; 190():46-53. PubMed ID: 29981942
[TBL] [Abstract][Full Text] [Related]
10. Pregabalin misuse-related ambulance attendances in Victoria, 2012-2017: characteristics of patients and attendances.
Crossin R; Scott D; Arunogiri S; Smith K; Dietze PM; Lubman DI
Med J Aust; 2019 Feb; 210(2):75-79. PubMed ID: 30712302
[TBL] [Abstract][Full Text] [Related]
11. The prevalence and correlates of gamma-hydroxybutyrate (GHB) overdose among Australian users.
Degenhardt L; Darke S; Dillon P
Addiction; 2003 Feb; 98(2):199-204. PubMed ID: 12534425
[TBL] [Abstract][Full Text] [Related]
12. A multicentre case series of analytically confirmed gamma-hydroxybutyrate intoxications in Western Australian emergency departments: Pre-hospital circumstances, co-detections and clinical outcomes.
Smith JL; Greene S; McCutcheon D; Weber C; Kotkis E; Soderstrom J; Douglas B; Lenton S; Grigg J; Dessauer P; Ezard N; Fatovich DM;
Drug Alcohol Rev; 2024 May; 43(4):984-996. PubMed ID: 38426636
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of oxycodone-related ambulance attendances: analysis of temporal trends and the effect of reformulation in Victoria, Australia from 2013 to 2018.
Nielsen S; Sanfilippo PG; Scott D; Lam T; Smith K; Lubman DI
Addiction; 2021 Aug; 116(8):2233-2241. PubMed ID: 33296537
[TBL] [Abstract][Full Text] [Related]
14. Presentations to an urban emergency department in Switzerland due to acute γ-hydroxybutyrate toxicity.
Liakoni E; Walther F; Nickel CH; Liechti ME
Scand J Trauma Resusc Emerg Med; 2016 Aug; 24(1):107. PubMed ID: 27581664
[TBL] [Abstract][Full Text] [Related]
15. Increasing emergency department attendances in central London with methamphetamine toxicity and associated harms.
Harnett JT; Dargan PI; Dines AM; Archer JRH; Greene SL; Hunter LJ; Wood DM
Emerg Med J; 2022 Jun; 39(6):463-466. PubMed ID: 34649939
[TBL] [Abstract][Full Text] [Related]
16. Commentary on Arunogiri et al. (2020): Findings from surveillance of patterns of drug use and related harms need careful interpretation, promotion and response.
Dietze P; Horyniak D
Addiction; 2020 Mar; 115(3):480-481. PubMed ID: 31849134
[No Abstract] [Full Text] [Related]
17. Trends in quetiapine use and non-fatal quetiapine-related ambulance attendances.
Heilbronn C; Lloyd B; McElwee P; Eade A; Lubman DI
Drug Alcohol Rev; 2013 Jul; 32(4):405-11. PubMed ID: 23350582
[TBL] [Abstract][Full Text] [Related]
18. Opioid-related ambulance attendances during the first 2 years of the COVID-19 pandemic in Victoria, Australia.
McGrath M; Stare M; Chua P; Ogeil R; Nehme Z; Scott D; Lubman DI
Addiction; 2024 Feb; 119(2):348-355. PubMed ID: 37816493
[TBL] [Abstract][Full Text] [Related]
19. Gamma-hydroxybutyrate: a 30 month emergency department review.
Munir VL; Hutton JE; Harney JP; Buykx P; Weiland TJ; Dent AW
Emerg Med Australas; 2008 Dec; 20(6):521-30. PubMed ID: 19125832
[TBL] [Abstract][Full Text] [Related]
20. Aggression and violence at ambulance attendances where alcohol, illicit and/or pharmaceutical drugs were recorded: A 5-year study of ambulance records in Victoria, Australia.
Coomber K; Curtis A; Vandenberg B; Miller PG; Heilbronn C; Matthews S; Smith K; Wilson J; Moayeri F; Mayshak R; Lubman DI; Scott D
Drug Alcohol Depend; 2019 Dec; 205():107685. PubMed ID: 31704380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
